The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
Share
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
Building the Military Health System’s AI Ecosystem
DHA and Red Hat discuss building a secure AI ecosystem, strengthening data foundations and ensuring safe AI use in military health care.
10m watch -
Geopolitical Tensions Highlight Need for Resilient AI Supply Chains
The U.S. is working with global partners to strengthen AI supply chains and ensure continuity amid growing geopolitical risks.
3m read -
NOAA Improves Geospatial Accuracy With NSRS Modernization
NOAA is integrating GPS and new gravity data to improve accuracy of its National Spatial Reference System.
9m listen -
Resilience Ops are the Foundation of Federal AI, Cloud and Data Recovery
Resilience strategies in the age of AI must include frameworks for managing and recovering data.
28m watch
